|
CDC42SE2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.549000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.444400E-01 |
| Normal-vs-Stage2 |
5.421800E-01 |
| Normal-vs-Stage3 |
6.866600E-01 |
| Normal-vs-Stage4 |
8.627200E-01 |
| Stage1-vs-Stage2 |
5.773000E-01 |
| Stage1-vs-Stage3 |
6.478800E-01 |
| Stage1-vs-Stage4 |
8.976200E-01 |
| Stage2-vs-Stage3 |
3.909600E-01 |
| Stage2-vs-Stage4 |
5.990400E-01 |
| Stage3-vs-Stage4 |
8.981800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.749000E-01 |
| Normal-vs-AfricanAmerican |
8.343200E-01 |
| Normal-vs-Asian |
4.111800E-01 |
| Caucasian-vs-AfricanAmerican |
7.095200E-01 |
| Caucasian-vs-Asian |
6.186200E-01 |
| AfricanAmerican-vs-Asian |
6.191600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.342600E-01 |
| Normal-vs-Female |
2.941400E-01 |
| Male-vs-Female |
1.694160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.247400E-01 |
| Normal-vs-Extreme_Weight |
9.081000E-01 |
| Normal-vs-Obese |
5.634000E-01 |
| Normal-vs-Extreme_Obese |
1.891620E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.815200E-01 |
| Normal_Weight-vs-Obese |
3.689400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.661800E-01 |
| Extreme_Weight-vs-Obese |
6.634000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.420020E-01 |
| Obese-vs-Extreme_Obese |
8.699800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.280200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.801600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.040770E-01 |
| Normal-vs-Age(81-100Yrs) |
4.718600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.192200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.445800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.786200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.205700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.077600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.247200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.428800E-01 |
| Normal-VS-Type2 PRCC |
4.917200E-01 |
| Normal-VS-KIRP CIMP |
2.546800E-01 |
| Normal-VS-Unclassified PRCC |
6.165200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.448010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.240000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.816800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.272600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.997600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.090800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.269800E-01 |
| Normal-vs-N1 |
9.648200E-01 |
| Normal-vs-N2 |
6.341200E-01 |
| N0-vs-N1 |
3.451000E-01 |
| N0-vs-N2 |
4.575000E-01 |
| N1-vs-N2 |
7.502000E-01 |
|
|
